<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Encounter Summary</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">Alfred T Molyneaux</td></tr><tr><td class="td_header_role_name"><span class="td_label">Previous Name</span></td><td class="td_header_role_value">Alfred Molyneaux</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">March 2, 1948 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Black or African American</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Not Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Previous Address:<br/>7 Wales St Unit 1<br/>DORCHESTER, MA 02124-1610, United States of America<br/>Effective Date: February 12, 2014 <br/>Expiration Date: March 25, 2014 <br/><br/> Primary Home Address:<br/>7 WALES ST<br/>Unit 1<br/>DORCHESTER, MA 02124-1610, United States of America<br/>Effective Date: March 10, 2022 <br/><br/> Temporary Address:<br/>9 WALES STREET<br/>BOSTON, MA 02124<br/><br/>Primary Home Phone:  +1-617-265-6819<br/>Mobile Phone:  +1-646-737-5996<br/>Email:  alfredmolyneaux@yahoo.com<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">PX6HN9F5T4T9XBB 1.2.840.114350.1.13.362.2.7.3.688884.100<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value"> 1.2.840.114350.1.13.362.2.7.8.688883.1368034739</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">August 26, 2024, 13:53:24 -0400 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Nibal Ahmad Harati,  MD of Mass General Brigham</td></tr><tr><td class="td_header_role_value internal_format"> Work Address:<br/>67 Coddington St<br/>Unit 104<br/>QUINCY, MA 02169, United States of America<br/><br/>Work Phone:  +1-617-479-0202<br/>Fax:  +1-617-479-1692<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">Epic - Version 10.6</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">3590153784 1.2.840.114350.1.13.362.2.7.3.698084.8</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">Office Visit</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From June 6, 2024, 10:45:00 -0400  to June 6, 2024, 11:00:00 -0400 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">MGH Claire and John Bertucci Ctr Genitourinary Cancers of </td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">Matthew R Smith of Mass General Brigham</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Work Address:<br/>55 Fruit St<br/>Boston, MA 02114<br/><br/>Work Phone:  +1-617-724-4000<br/>Fax:  +1-617-726-8685<br/>Email:  MRSMITH@mgh.harvard.edu<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Emergency contact</span></td><td class="td_header_role_value">Jean Molyneaux<br/><br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Primary Home Address:<br/>12 OWENCROFT STREET<br/>BOSTON 02124, United States of America<br/><br/>Primary Home Phone:  +1-617-288-5891<br/>Mobile Phone:  +1-617-288-5891<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Emergency contact</span></td><td class="td_header_role_value">Angela (niece) Molyneaux<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Primary Home Address:<br/>12 OWENCROFT STREET<br/>DORCHESTER, MA 02124, United States of America<br/><br/>Primary Home Phone:  +1-617-605-0051<br/>Mobile Phone:  +1-617-605-0051<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">Deborah A. Adair signed at August 26, 2024, 13:53:24 -0400 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">Mass General Brigham</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Work Address:<br/>617-726-2361<br/>399 Revolution Drive<br/>Suite 985<br/>SOMERVILLE, MA 02145, United States of America<br/><br/><br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Encounter Details</a></li><li><a href="#id2">Social History</a></li><li><a href="#id3">Last Filed Vital Signs</a></li><li><a href="#id4">Functional Status</a></li><li><a href="#id5">Patient Instructions</a></li><li><a href="#id6">Progress Notes</a></li><li><a href="#id7">Plan of Treatment</a></li><li><a href="#id8">Goals</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Results</a></li><li><a href="#id11">Visit Diagnoses</a></li><li><a href="#id12">Administered Medications</a></li><li><a href="#id13">Additional Health Concerns</a></li><li><a href="#id14">Care Teams</a></li><li><a href="#id15">Additional Source Comments</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter1" class="xRowNormal"><td>06/06/2024 10:45 AM EDT</td><td ID="encounter1type">Office Visit</td><td><p>MGH Claire and John Bertucci Ctr Genitourinary Cancers</p><p>55 Fruit St</p><p>Yawkey 7E</p><p>Boston, MA 02114</p><p>617-724-4000</p></td><td><p>Smith, Matthew R, MD, PhD</p><p>55 Fruit St</p><p>Boston, MA 02114</p><p>617-724-4000 (Work)</p><p>617-726-8685 (Fax)</p><p>MRSMITH@mgh.harvard.edu</p></td><td><span class="content_span">Malignant tumor of prostate (Primary Dx)</span></td></tr></tbody></table></div><h3><a name="id2" href="#toc">Social History</a></h3><div><table ID="sochist6"><colgroup><col width="25%" span="2"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Never</td><td/><td ID="sochist6packsperday"/><td/><td/></tr><tr ID="sochist6smokeless" class="xRowAlt"><td>Smokeless Tobacco: Never</td><td/><td/><td/><td/></tr></tbody></table><table ID="sdohassess1"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Education</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess1pair1"><td ID="sdohassess1pair1ques">Are you interested in more education?</td><td ID="sdohassess1pair1ans">Not on file</td><td>04/27/2023</td></tr><tr ID="sdohassess1pair2"><td ID="sdohassess1pair2ques">Are you concerned about learning?</td><td ID="sdohassess1pair2ans">Not on file</td><td>04/27/2023</td></tr><tr ID="sdohassess1pair3"><td ID="sdohassess1pair3ques"/><td ID="sdohassess1pair3ans">No</td><td>04/27/2023</td></tr><tr ID="sdohassess1pair4"><td ID="sdohassess1pair4ques"/><td ID="sdohassess1pair4ans">No</td><td>04/27/2023</td></tr></tbody></table><table ID="sdohassess2"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Digital Access</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess2pair1"><td ID="sdohassess2pair1ques"/><td ID="sdohassess2pair1ans">No</td><td>05/29/2023</td></tr><tr ID="sdohassess2pair2"><td ID="sdohassess2pair2ques"/><td ID="sdohassess2pair2ans">No</td><td>05/29/2023</td></tr><tr ID="sdohassess2pair3"><td ID="sdohassess2pair3ques"/><td ID="sdohassess2pair3ans">No</td><td>05/29/2023</td></tr><tr ID="sdohassess2pair4"><td ID="sdohassess2pair4ques">Reliable internet access at home?</td><td ID="sdohassess2pair4ans">Not on file</td><td>05/29/2023</td></tr><tr ID="sdohassess2pair5"><td ID="sdohassess2pair5ques">Device with a working camera?</td><td ID="sdohassess2pair5ans">Not on file</td><td>05/29/2023</td></tr></tbody></table><table><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex9"><td>Sex Assigned at Birth</td><td ID="BirthSex9Value">Male</td><td>03/07/2023 10:10 AM EST</td></tr><tr ID="GenderIdentity7"><td>Gender Identity</td><td ID="GenderIdentity7Value">Male</td><td>03/07/2023 10:06 AM EST</td></tr><tr ID="SexualOrientation8"><td>Sexual Orientation</td><td ID="SexualOrientation8Value">Straight</td><td>03/07/2023 10:10 AM EST</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id3" href="#toc">Last Filed Vital Signs</a></h3><div><table><colgroup><col width="25%" span="4"/></colgroup><thead><tr><th>Vital Sign</th><th>Reading</th><th>Time Taken</th><th>Comments</th></tr></thead><tbody><tr class="xRowNormal"><td class="xcellHeader">Blood Pressure</td><td><span class="content_span">109</span>/<span class="content_span">71</span></td><td>06/06/2024 10:55 AM EDT</td><td/></tr><tr ID="pulse_5788594500" class="xRowAlt"><td class="xcellHeader">Pulse</td><td>69</td><td>06/06/2024 10:55 AM EDT</td><td/></tr><tr ID="temp_5788594500" class="xRowNormal"><td class="xcellHeader">Temperature</td><td>36.1 °C (97 °F)</td><td>06/06/2024 10:55 AM EDT</td><td/></tr><tr ID="resp_5788594500" class="xRowAlt"><td class="xcellHeader">Respiratory Rate</td><td>18</td><td>06/06/2024 10:55 AM EDT</td><td/></tr><tr ID="SpO2_5788594500" class="xRowNormal"><td class="xcellHeader">Oxygen Saturation</td><td>98%</td><td>06/06/2024 10:55 AM EDT</td><td/></tr><tr ID="inhaled_" class="xRowAlt"><td class="xcellHeader">Inhaled Oxygen Concentration</td><td>-</td><td>-</td><td/></tr><tr ID="weight_5788594500" class="xRowNormal"><td class="xcellHeader">Weight</td><td>92.1 kg (203 lb)</td><td>06/06/2024 10:55 AM EDT</td><td/></tr><tr ID="height_" class="xRowAlt"><td class="xcellHeader">Height</td><td>-</td><td>-</td><td/></tr><tr ID="bmi_5788594500" class="xRowNormal"><td class="xcellHeader">Body Mass Index</td><td>29.13</td><td>08/11/2020  9:11 AM EDT</td><td/></tr></tbody></table>documented in this encounter</div><h3><a name="id4" href="#toc">Functional Status</a></h3><div><span class="content_span">Not on file</span>documented as of this encounter</div><h3><a name="id5" href="#toc">Patient Instructions</a></h3><div><span class="content_span">Not on file</span>documented in this encounter</div><h3><a name="id6" href="#toc">Progress Notes</a></h3><div><ul><li>Smith, Matthew R, MD, PhD - 06/06/2024 10:45 AM EDT: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/>MGH Cancer Center<br/><br/>VISIT DIAGNOSIS<br/>recurrent metastatic prostate cancer<br/><br/>PROSTATE CANCER HISTORY<br/>2/2008 admitted to Carney Hospital for hyperglycemia and diagnosed with diabetes. During workup, Ct scan revealed enlarged prostate. He had<br/>a biopsy done 4/2008. MGH review revealed adenocarcinoma involving all cores, gleason score 4+3. PSA at Carney Hospital was 19.8. He also<br/>states he had a bone scan 6/2008 which was normal.<br/><br/>2/2009 prostatectomy by Dr McGovern, pT3aNx Gleason 3+4; posoperative PSA &lt;0.1<br/><br/>5/2011-present: rising PSA<br/><br/>2013 sling placement for urinary incontinence; initial improvement but subsequent decline in urinary control. It is now greatly affecting the<br/>quality of his life and he has been meeting with Dr Heney to discuss an artifiical urinary sphincter.<br/><br/>12/2014 surgery for artificial urinary sphincter placement. He asked to have the sphincter deactivated "because I wasn't comfortable using it"<br/><br/>5/2017 restaging for rising PSA; bone scan demonstrated focal high uptake in the right frontoparietal skull.  Head CT demonstrated 14 mm densely sclerotic lesion within the right frontal bone, corresponding to the site of high uptake on the prior bone scan, highly suspicious for a sclerotic osseous metastasis.<br/><br/>8/2017-7/2018: ADT with leuprolide depot; pretreatment PSA 6.88; PSA nadir &lt;0.10<br/><br/>8/2018-8/2020: treatment holiday<br/><br/>8/2020-present: ADT with leuprolide depot; pretreatment PSA 29<br/><br/>PMH<br/>no history of inflammatory bowel disease or diverticulitis<br/>diabetes mellitus- dx 2/2008<br/>incontinence, s/p male sling surgery and later AUS<br/><br/>NKDA<br/><br/>SH: Single. He has 2 adult children ages 25 and 31. He never smoked and he rarely drinks alcohol. He worked in banking for 40 years. He<br/>has been out of work for recent years. He is a leader in his church.<br/><br/>FH: Noncontributory.<br/><br/>ROS<br/>Performance Status: 0<br/>Stable weight<br/>No bone pain<br/>No change in bowel habits<br/>No spontaneous erections<br/>+urinary incontinence<br/>All other organ systems are normal<br/><br/>EXAM<br/>General: well appearing<br/>Psychiatric: no apparent distress<br/>Skin: no ecchymoses, rash, or jaundice<br/>Eyes: no scleral icterus<br/>Lymphatic: no palpable nodes<br/>Cardiovascular: regular rate and rhythym, normal S1 and S2, no peripheral edema<br/>Respiratory: chest is clear to ascultation bilaterally<br/>Gastrointestinal: Abdomen is soft, NT no palpable masses, or organomegaly<br/>Musculoskeletal: normal gait, muscle tone and strength<br/>Neurological: alert, oriented, appropriate, normal gait <br/><br/>LABORATORY<br/><br/>Lab Results <br/>Component Value Date/Time <br/> WBC 5.64 06/04/2021 09:16 AM <br/> HGB 12.9 (L) 06/04/2021 09:16 AM <br/> HCT 38.7 (L) 06/04/2021 09:16 AM <br/> MCV 88.2 06/04/2021 09:16 AM <br/> PLT 199 06/04/2021 09:16 AM <br/><br/>Lab Results <br/>Component Value Date/Time <br/> SODIUM 139 06/03/2022 09:39 AM <br/> POTASSIUM 4.3 06/03/2022 09:39 AM <br/> CHLORIDE 103 06/03/2022 09:39 AM <br/> CO2 25 06/03/2022 09:39 AM <br/> BUN 12 06/03/2022 09:39 AM <br/> CALCIUM 9.5 06/03/2022 09:39 AM <br/> EGFR 74 06/03/2022 09:39 AM <br/> TOTAL BILIRUBIN 0.8 06/03/2022 09:39 AM <br/><br/>Lab Results <br/>Component Value Date <br/> TES 36 (L) 03/01/2023 <br/><br/>Lab Results <br/>Component Value Date/Time <br/> PT 13.4 09/21/2012 03:11 PM <br/><br/>Lab Results <br/>Component Value Date <br/> PSAMON 0.12 03/05/2024 <br/> PSAMON &lt;0.10 12/05/2023 <br/> PSAMON &lt;0.10 09/05/2023 <br/><br/>RADIOLOGY<br/><br/>NM Bone Scan Whole Body<br/>Performed: 9/14/2020 at  4:37 PM <br/>Reason For Exam<br/><br/>*Prostate cancer, staging <br/> PACS Images<br/><br/> Show images for NM Bone Scan <br/> <br/>Impression<br/><br/> <br/>Interval progression in the intensity of previously identified metastatic lesions of skull and rib, without convincing new abnormality. <br/> <br/> <br/> <br/>Narrative<br/><br/>NM BONE SCAN WHOLE BODY <br/> <br/>Radionuclide bone scan: <br/> <br/>COMPARISON: 4/11/2017 <br/> <br/>TECHNIQUE:   <br/>19.1 mCi technetium 99m MDP was injected.  Scans were performed more than two hours later.  Whole body images were acquired and appropriate spot views were obtained based upon review of the whole body images. <br/> <br/>FINDINGS:   <br/> <br/>Since the prior study, there has been interval progression in the intensity of the previously identified abnormality in the right frontal skull., There has been interval increase in a previously subtle abnormality of the left anterolateral rib, probably the sixth rib. Uptake at the costochondral junction of the right sixth rib is stable. <br/> <br/>There has been no substantial change in minor uptake at T12, likely degenerative. There is slightly more prominent uptake in the mid lumbar spine, likely degenerative. <br/> <br/>There is stable intense uptake in the right shoulder consistent with arthropathy. Multiple other regions of periarticular uptake is consistent with degenerative change. <br/> <br/><br/>ASSESSMENT<br/>76 year old man with metastatic prostate cancer<br/>Sites of disease: bone including small densely sclerotic lesion within the right frontal bone by CT corresponding to the site of high uptake on the prior bone scan, highly suspicious for a sclerotic osseous metastasis.<br/>Prior local therapy: prostatectomy in 2009 with pT3aNx prostate cancer, Gleason 3+4, with negative surgical margins<br/><br/>On intermittent ADT with leuprolide depot since 8/2017; decline in PSA c/w response to treatment. <br/>On continuous ADT since 8/2020<br/>Decline in PSA c/w response to ADT<br/><br/>We discussed his diagnosis, recent test results, expected natural history of his cancer and range of individual outcomes, and plan for ongoing management.  We discussed the metrics to assess his disease status.<br/><br/>We reviewed the rationale for androgen deprivation therapy (ADT), expected benefits and harms, and metrics to assess efficacy of treatment.  We specifically discussed potential adverse effects of ADT including fatigue, loss of sexual interest and ability, hot flashes, weight gain, fat accumulation, muscle loss, osteoporosis/fractures, and possibly greater risk for diabetes and cardiovascular disease. We discussed survivorship plan to mitigate adverse effects during ADT including hot flashes, fatigue, body composition changes, and metabolic alterations. <br/><br/>PLAN<br/>Continue ADT with leuprolide depot with plan for continuous treatment; leuprolide 6-month depot due in September 2024 (last dose 3/07/2024)<br/>Serial PSA <br/>Restage at PSA progression despite continuous ADT<br/>Encourage healthy diet and exercise<br/>Return to clinic in 3 months<br/><br/>Matthew R. Smith, M.D., Ph.D. <br/>Professor of Medicine, Harvard Medical School<br/>Director, Genitourinary Oncology Program<br/>Massachusetts General Hospital Cancer Center<br/>Yawkey 7030<br/>55 Fruit Street<br/>Boston, MA 02114<br/>617-724-5257<br/>617-726-4899 (fax)<br/>Pager: 11777<br/>smith.matthew@mgh.harvard.edu?<br/><br/></content><br/><span class="xLabel">Electronically signed by Smith, Matthew R, MD, PhD at 06/06/2024 11:11 AM EDT</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id7" href="#toc">Plan of Treatment</a></h3><div><table><span style="font-weight:bold; ">Upcoming Encounters</span><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter29" class="xRowNormal"><td>09/05/2024 10:45 AM EDT</td><td ID="encounter29type">Office Visit</td><td><p>MGH Claire and John Bertucci Ctr Genitourinary Cancers</p><p>55 Fruit St</p><p>Yawkey 7E</p><p>Boston, MA 02114</p><p>617-724-4000</p></td><td><p>Smith, Matthew R, MD, PhD</p><p>55 Fruit St</p><p>Boston, MA 02114</p><p>617-724-4000 (Work)</p><p>617-726-8685 (Fax)</p><p>MRSMITH@mgh.harvard.edu</p></td><td/></tr><tr ID="encounter28" class="xRowAlt"><td>09/05/2024 11:15 AM EDT</td><td ID="encounter28type">Infusion</td><td><p>MGH Claire and John Bertucci Ctr Genitourinary Cancers</p><p>55 Fruit St</p><p>Yawkey 7E</p><p>Boston, MA 02114</p><p>617-724-4000</p></td><td><p>Smith, Matthew R, MD, PhD</p><p>55 Fruit St</p><p>Boston, MA 02114</p><p>617-724-4000 (Work)</p><p>617-726-8685 (Fax)</p><p>MRSMITH@mgh.harvard.edu</p></td><td/></tr></tbody></table><table><span style="font-weight:bold; ">Scheduled Orders</span><colgroup><col width="25%"/><col width="15%"/><col width="10%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Name</th><th>Type</th><th>Priority</th><th>Associated Diagnoses</th><th>Order Schedule</th></tr></thead><tbody><tr ID="procedure31"><td><span class="content_span">PSA diagnostic (monitoring)</span></td><td>Lab</td><td>Routine</td><td><p>Malignant tumor of prostate</p></td><td ID="procedure31schedule">Expected: 06/06/2024, Expires: 06/06/2025</td></tr><tr ID="procedure32"><td><span class="content_span">Testosterone, total</span></td><td>Lab</td><td>Routine</td><td><p>Malignant tumor of prostate</p></td><td ID="procedure32schedule">Expected: 06/06/2024, Expires: 06/06/2025</td></tr><tr ID="procedure33"><td><span class="content_span">Comprehensive metabolic panel</span></td><td>Lab</td><td>Routine</td><td><p>Malignant tumor of prostate</p></td><td ID="procedure33schedule">Expected: 06/06/2024, Expires: 06/06/2025</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id8" href="#toc">Goals</a></h3><div><span class="content_span">Not on file</span>documented as of this encounter</div><h3><a name="id9" href="#toc">Procedures</a></h3><div><span class="content_span">Not on file</span>documented in this encounter</div><h3><a name="id10" href="#toc">Results</a></h3><div><span class="content_span">Not on file</span>documented in this encounter</div><h3><a name="id11" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx2" class="xRowNormal"><td><p><span class="content_span">Malignant tumor of prostate</span><span class="content_span"> - Primary</span></p><p>Malignant neoplasm of prostate</p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id12" href="#toc">Administered Medications</a></h3><div><span class="content_span">Not on file</span>documented in this encounter</div><h3><a name="id13" href="#toc">Additional Health Concerns</a></h3><div><span class="content_span">Not on file</span>documented as of this encounter</div><h3><a name="id14" href="#toc">Care Teams</a></h3><div><table ID="ct48"><colgroup><col width="25%" span="3"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>Harati, Nibal Ahmad, MD</p><p>NPI: 1861597254</p><p>67 Coddington St</p><p>Unit 104</p><p>QUINCY, MA 02169</p><p>617-479-0202 (Work)</p><p>617-479-1692 (Fax)</p></td><td>PCP - General</td><td>Internal Medicine</td><td>3/7/23</td><td/></tr></tbody></table>documented as of this encounter</div><h3><a name="id15" href="#toc">Additional Source Comments</a></h3><div>The information contained in this document represents components of the legal health record. It is not the complete legal health record.Mass General Brigham</div><br/><br/></body></html>